XML 42 R31.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity (Tables)

3 Months Ended

Jun. 30, 2022

Schedule of Stock Option and RSU and PSU Award Activities

The following table summarizes the Company’s stock option, restricted stock unit (“RSU”), and performance-based restricted stock unit (“PSU”) award activities for the three months ended June 30, 2022 (in thousands, except exercise price, contractual term and fair value information):


	Options Outstanding						RSUs Outstanding						PSUs Outstanding
	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value		Number of Shares	Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value		Number of Shares	Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding - April 1, 2022	1,663	$	54.66	5.6	$	31,436	3,351	$	70.04	2.6	$	224,096	320	$	86.88	1.8	$	21,430
Granted	—	—					1,788	45.81					181	57.95
Exercised/vested	(96)	18.00			3,821		(328)	71.66					(130)	89.05
Canceled/forfeited	(44)	65.60					(309)	63.53					(3)	99.05
Outstanding - June 30, 2022	1,523	$	56.65	5.3	$	13,548	4,502	$	60.74	2.6	$	225,344	368	$	71.81	2.2	$	18,409

Schedule of Stock-based Compensation Expense Attributed to Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses

Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):


	Three Months Ended June 30,
	2022		2021
Cost of revenue	$	1,344	$	1,072
Research and development	13,286		10,964
Sales and marketing	10,583		11,534
General and administrative (1)	9,669		18,617
Total stock-based compensation expense (2)	$	34,882	$	42,187

(1) Includes $9.6 million acceleration of share-based payment expense for the three months ended June 30, 2021, for one of the Company’s executives due to his departure at the end of June 2021. There was no corresponding expense for the three months ended June 30, 2022.

(2) Includes $0.5 million expense for the three months ended June 30, 2021, due to the restructuring activities commenced in the first quarter of fiscal 2022. There was no corresponding expense for the three months ended June 30, 2022. Refer to Note 16 — Restructuring for more information.